Brain derived neurotrophic factor expression in immune cells affects therapeutic efficacy of glatiramer acetate in experimental autoimmune encephalomyelitis

被引:0
|
作者
Linker, Ralf A.
Siglienti, Ines
Lee, De-Hyung
Luhder, Fred
Sendtner, Michael
Gold, Ralf
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A339 / A339
页数:1
相关论文
共 50 条
  • [21] Glatiramer acetate induced Foxp3 regulatory T-cells contribute to its therapeutic effect in experimental autoimmune encephalomyelitis
    Aharoni, R.
    Amor, V.
    Shezen, E.
    Vainshtein, A.
    Arnon, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S191 - S191
  • [22] Neurotrophic factors and neuroinflammation: Experimental autoimmune encephalomyelitis in conditional BDNF-knock-out mice and effective treatment with glatiramer acetate
    Siglienti, I
    Linker, RA
    Lee, DH
    Luehder, F
    Wiese, S
    Sendtner, M
    Gold, R
    NEUROLOGY, 2006, 66 (05) : A194 - A194
  • [23] Neurotrophic factors and neuroinflammation: experimental autoimmune encephalomyelitis in conditional BDNF-knock out mice and effective treatment with glatiramer acetate
    Lee, D.
    Linker, R.
    Siglienti, I.
    Luehder, F.
    Kruse, N.
    Sendtner, M.
    Gold, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S138 - S138
  • [24] Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
    Aharoni, Rina
    Saada, Ravit
    Eilam, Raya
    Hayardeny, Liat
    Sela, Michael
    Arnon, Ruth
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 251 (1-2) : 14 - 24
  • [25] Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
    Aharoni, R.
    Saada, R.
    Eilam, R.
    Hayardeny, L.
    Sela, M.
    Arnon, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 203 - 204
  • [26] Effect of glatiramer acetate on the cytokine profile and brain derived neurotrophic factor in multiple sclerosis:: a longitudinal study
    Blanco, Y
    Alonso-Magdalena, L
    Costa, M
    Gómez-Choco, M
    Torres, EM
    Alberch, J
    Jaraquemada, D
    Urdiain, TA
    Graus, F
    Saiz, A
    MULTIPLE SCLEROSIS, 2005, 11 : S87 - S87
  • [27] Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate
    Azoulay, D
    Vachapova, V
    Shihman, B
    Miler, A
    Karni, A
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 167 (1-2) : 215 - 218
  • [28] Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis
    Begum-Haque, Sakhina
    Sharma, Alok
    Christy, Marc
    Lentini, Tim
    Ochoa-Reparaz, Javier
    Fayed, Islam F.
    Mielcarz, Daniel
    Haque, Azizul
    Kasper, Lloyd H.
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 219 (1-2) : 47 - 53
  • [29] Magnetic Resonance Imaging (MRI) Characterization of the Therapeutic Effect of Glatiramer Acetate in Different Models of Experimental Autoimmune Encephalomyelitis (EAE)
    Aharoni, Rina
    Sason, Efrat
    Sela, Michael
    Arnon, Ruth
    NEUROLOGY, 2012, 78
  • [30] Secretion of brain-derived neurotrophic factor (BDNF), interleukin 10 and transforming growth factor beta by glatiramer acetate specific T-cells in the brain
    Aharoni, R
    Kayhan, B
    Sela, M
    Arnon, R
    NEUROLOGY, 2004, 62 (07) : A111 - A111